+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

International Business Machines Corp (IBM) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 139 Pages
  • July 2026
  • Region: Global
  • GlobalData
  • IBM
  • ID: 4479947
International Business Machines Corp (IBM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

International Business Machines Corp (IBM) is a provider of global hybrid cloud and AI, and consulting solutions and services. The company develops system hardware and software, and offers infrastructure, hosting, financing solution and consulting services. The company provides its software and services in various areas including analytics, artificial intelligence, automation, blockchain, cloud computing, IT infrastructure, IT management, cybersecurity, and software development. The company also offers cloud, networking, security, technology consulting, application services, business resilience services, and technology support services. It serves automotive, banking and financial markets, electronics, energy and utilities, healthcare, insurance, life sciences, manufacturing, metals and mining, retail and consumer products, travel, and telecom industries. The company’s business operations span across the world. IBM is headquartered in Armonk, New York, the US.

International Business Machines Corp Key Recent Developments

  • Jun 17, 2026: IBM Study Finds Limited Control and Rising Dependencies Expose Enterprises in the Age of AI
  • Jun 02, 2026: Europe's Tech Sovereignty: Control, Choice and Independence
  • May 19, 2026: AusNet Launches Unified Customer Connections Platform To Accelerate Services Amid Rising Grid Demand
  • May 19, 2026: What Makes an IoT Cloud Platform Scalable?

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Exelixis Inc - Key Facts
  • Exelixis Inc - Key Employees
  • Exelixis Inc - Key Employee Biographies
  • Exelixis Inc - Major Products and Services
  • Exelixis Inc - History
  • Exelixis Inc - Company Statement
  • Exelixis Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Exelixis Inc - Business Description
  • Other Break-up: License Revenues
  • Performance
  • Other Break-up: Net Product Revenues
  • Performance
  • Geographical Segment: Europe
  • Performance
  • Geographical Segment: Japan
  • Performance
  • Geographical Segment: U.S.
  • Performance
  • R&D Overview
  • Exelixis Inc - Corporate Strategy
  • Exelixis Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Exelixis Inc - Strengths
  • Exelixis Inc - Weaknesses
  • Exelixis Inc - Opportunities
  • Exelixis Inc - Threats
  • Exelixis Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Exelixis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • Exelixis Inc, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
  • Exelixis Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Jun 22, 2026: Exelixis Updates Phase 3 STELLAR-303 Trial of Zanzalintinib Plus Atezolizumab in Metastatic Colorectal Cancer
  • May 19, 2026: Exelixis and Merck Collaborate on Phase 3 STELLAR-316 Trial for Resected Colorectal Cancer
  • Apr 15, 2026: Cancer Dependency Map Consortium launches Phase 3 to accelerate next-generation therapeutics
  • Feb 09, 2026: Peptistar Receives the 2025 Best CDMO Award from Exelixis
  • Oct 20, 2025: Exelixis Reports Phase 3 STELLAR-303 Trial Results for Zanzalintinib in Metastatic Colorectal Cancer
  • Oct 18, 2025: Exelixis Reports CABINET Phase 3 Trial Results for CABOMETYX in Advanced Lung and Thymic Neuroendocrine Tumors
  • Aug 29, 2025: Exelixis Announces Appointment of Dana T. Aftab, Ph.D. as Executive Vice President, Research and Development
  • Aug 27, 2025: Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in September
  • Jul 28, 2025: Exelixis Announces Second Quarter 2025 Financial Results and Provides Corporate Update
  • Feb 11, 2025: Exelixis Announces Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Corporate Update
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Exelixis Inc, Key Facts
  • Exelixis Inc, Key Employees
  • Exelixis Inc, Key Employee Biographies
  • Exelixis Inc, Major Products and Services
  • Exelixis Inc, History
  • Exelixis Inc, Subsidiaries
  • Exelixis Inc, Key Competitors
  • Exelixis Inc, Ratios based on current share price
  • Exelixis Inc, Annual Ratios
  • Exelixis Inc, Interim Ratios
  • Exelixis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • Exelixis Inc, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
  • Exelixis Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Exelixis Inc, Performance Chart (2021 - 2025)
  • Exelixis Inc, Ratio Charts
  • Exelixis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • Exelixis Inc, Pharmaceuticals & Healthcare, Deals by Type, 2020 to YTD 2026